Will the ACS and ASCO online resource launch be deemed successful by July 31, 2024? | Binary | | | 7 months ago | |
Will ACS and ASCO announce another partnership expansion by the end of 2024? | Binary | | | 7 months ago | |
Will there be a significant increase in utilization of the ACS and ASCO online cancer resources by September 30, 2024? | Binary | | | 7 months ago | |
Which section of the new ACS and ASCO online cancer resource will be the most visited by the end of 2024? | Categorical | | | 7 months ago | |
What type of organization will ACS or ASCO announce a major partnership with next by the end of 2024? | Categorical | | | 7 months ago | |
What will be the primary source of traffic for the new ACS and ASCO online cancer resource by the end of 2024? | Categorical | | | 7 months ago | |
Will Novocure's market cap increase by 20% or more by the end of 2024? | Binary | | | 2 months ago | |
Will Optune Lua become the leading treatment for mNSCLC post-platinum chemotherapy by mid-2025? | Binary | | | 2 months ago | |
Will Optune Lua receive additional FDA approvals for other cancer indications by the end of 2025? | Binary | | | 2 months ago | |
How will Novocure's stock price change by the end of Q1 2025? | Categorical | | | 2 months ago | |
What will be Novocure's rank among top biotech companies by market cap by the end of 2025? | Categorical | | | 2 months ago | |
What percentage of mNSCLC patients will adopt Optune Lua by the end of 2025? | Categorical | | | 2 months ago | |
